自閉スペクトラム症治療の市場規模、シェア＆動向分析レポート：治療タイプ別（覚醒剤、抗精神病薬）、用途別、流通チャネル別、地域別、セグメント別予測、2023年～2030年

自閉スペクトラム症治療市場の成長・動向

Grand View Research, Inc.の新しいレポートによると、世界の自閉スペクトラム症治療市場規模は、2023年から2030年にかけてCAGR6.1％で拡大し、2030年には32億8000万米ドルに達すると予測されています。学術研究や製薬会社のパイプラインにある実験的な自閉スペクトラム症（ASD）薬の多くは、遺伝的指紋と脳が自閉症の発症にどのように寄与するかについての重要な理論を評価しています。パイプライン薬の中には、アクシアル・セラピューティクス社のAB-2004 &AB-2004 PTR、ザイネルバ・ファーマスーティカルズ社のZygel、インペル・ファーマスーティカルズ社のINP105（Olanzapine）などが含まれます。

2022年7月、Impel Pharmaceuticals Inc.は、INP-105を自閉スペクトラム症（ASD）の青年における急性焦燥の治療に評価する第2a相試験において、最初の患者の投与を開始しました。同社は、POD（Precision Olfactory Delivery）技術により、注射をしなくても鼻の上部に薬を届け、薬の吸収率を高めることができます。このように、ドラッグデリバリーの技術進歩は市場を牽引すると予想されます。

2020年5月、HARMAN InternationalとF. Hoffmann-La Roche Ltd.は、ASD患者のためのデジタル治療プラットフォームを開発するための世界パートナーシップを締結しました。このパートナーシップの下、ハーマンとサムスンは、ASDの治療のための革新的な治療法を開発するために、F. Hoffmann-La Roche Ltd.の神経科学におけるリーダーシップと彼らの広範な技術を組み合わせました。

自閉スペクトラム症の研究開発に対する認知度や資金調達の高まりは、市場の成長にプラスに働くと期待されています。例えば、ローマ・サピエンツァ大学では毎年4月2日を「世界自閉症啓発デー」として祝い、医師や患者の間でこの病気とその治療効果に関する認知度を高めることを目的としています。さらに、2022年11月には、ディファイアンス郡発達障害委員会／グッドサマリタンスクールとアンドリュー・ジメネス自閉症基金が、ASDに関する認知度を高める取り組みを支援するため、Buckeye Roofing and Exteriorsオーナーから1000米ドルの寄付を受け、その後市場成長の機会を創出しました。

自閉スペクトラム症治療市場レポートハイライト

治療タイプ別では、2022年に覚せい剤セグメントが最大のシェアを占めました。これは、FDAが承認した病気の症状管理用の刺激剤が市場で入手可能であることに起因することができる

用途別では、自閉性障害分野が、同疾患の発生率の上昇により、2022年に市場を独占しました。3つのコホート研究により、ASDの発症率は2021年5月時点で人口の3％以上であることが判明している

病院薬局セグメントは、2022年に2番目に大きなシェアを占めました。この成長は、疾患を持つ患者の診断と治療のための入院患者の増加に起因することができる

医療従事者の自閉スペクトラム症治療に対する高い認識、治療薬の入手可能性、疾患有病率の増加などの要因から、2022年の世界市場は北米が支配的でした

目次

第1章 調査手法と範囲

• 市場セグメンテーションと範囲
  • セグメントの範囲
  • 地域範囲
• 調査手法
• 情報調達
  • 購入したデータベース
  • GVRの内部データベース
  • 二次情報
  • 1次調査
  • 1次調査内容
• 情報またはデータ分析
  • データ分析モデル
• 市場の策定と検証
• モデルの詳細
  • コモディティフロー分析
    • アプローチ：商品フローアプローチ
• 調査の仮定
• 二次情報一覧
• 略語一覧
• 目的

第2章 エグゼクティブサマリー

• 市場のスナップショット
• セグメントのスナップショット
• 競合のスナップショット

第3章 自閉スペクトラム症治療：市場変数、動向、および範囲

• 市場系列の見通し
  • 中枢神経系治療薬市場
• 浸透と成長の見通しのマッピング
• 規制状況
• 市場力学
• 市場促進要因分析
  • ASDの有病率の増加
  • 医師と患者の間でASDについての認識を高める
  • ASDの研究開発のための資金を増やす
• 市場抑制要因分析
  • 承認薬の不足
  • 標的治療の前臨床から臨床への翻訳の失敗
• PESTEL分析
• 業界分析- ポーターの5つの力
• パイプライン分析

第4章 自閉スペクトラム症治療市場：セグメント分析、治療タイプ別、2018年から2030年（百万米ドル）

• 自閉スペクトラム症治療市場：治療タイプの変動分析
• 抗精神病薬
  • 選択的セロトニン再取り込み阻害剤
  • 覚せい剤
  • 睡眠薬
  • その他

第5章 自閉スペクトラム症治療市場：セグメント分析、アプリケーション別、2018年から2030年（100万米ドル）

• 自閉スペクトラム症治療市場：アプリケーションの変動分析
• 自閉症
• アスペルガー症候群
• 広汎性発達障害
• その他

第6章 自閉スペクトラム症治療市場：セグメント分析、流通チャネル別、2018年から2030年（百万米ドル）

• 自閉スペクトラム症治療市場：流通経路の変動分析
• 病院薬局
• 小売薬局
• オンライン薬局

第7章 欧州の自閉スペクトラム症治療市場：薬物クラス、アプリケーション、投与経路、および流通チャネル別の地域推定・動向分析

• 北米
  • SWOT分析
  • 米国
    • 国のダイナミクス
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
  • カナダ
    • 国のダイナミクス
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
• 欧州
  • SWOT分析
  • 英国
    • 国のダイナミクス
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
    • 処方箋と調剤のシナリオ
  • ドイツ
    • 国のダイナミクス
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
  • フランス
    • 国のダイナミクス
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
  • イタリア
    • 国のダイナミクス
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
  • スペイン
    • 国のダイナミクス
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
  • デンマーク
    • 国のダイナミクス
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
  • スウェーデン
    • 国のダイナミクス
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
  • ノルウェー
    • 国のダイナミクス
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
  • その他欧州
• アジア太平洋地域
  • SWOT分析
  • 日本
    • 国のダイナミクス
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
    • 処方箋と調剤のシナリオ
  • 中国
    • 国のダイナミクス
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
  • インド
    • 国のダイナミクス
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
  • オーストラリア
    • 国のダイナミクス
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
  • 韓国
    • 国のダイナミクス
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
  • タイ
    • 国のダイナミクス
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
  • APACのその他諸国
• ラテンアメリカ
  • SWOT分析
  • ブラジル
    • 国のダイナミクス
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
    • 処方箋と調剤のシナリオ
  • メキシコ
    • 国のダイナミクス
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
  • アルゼンチン
    • 国のダイナミクス
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
• 中東およびアフリカ（MEA）
  • SWOT分析
  • 南アフリカ
    • 国のダイナミクス
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
  • サウジアラビア
    • 国のダイナミクス
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
  • アラブ首長国連邦
    • 国のダイナミクス
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
  • クウェート
    • 国のダイナミクス
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
  • MEAの残り

第8章 自閉スペクトラム症治療市場：競合分析

• 主要な市場参入企業別最近の動向と影響分析
  • 新製品の発売
  • 合併と買収
  • ライセンシング契約
  • カンファレンスとキャンペーン
• 会社の分類
  • イノベーター
  • 市場のリーダー
• ベンダー情勢
  • 主要なディストリビューターとチャネルパートナーのリスト
  • 主要顧客
• 公開会社
  • 主要企業の市場シェア分析、2022年
  • 会社の市況分析
  • ヒートマップ分析
  • 競合ダッシュボード分析
    • 市場の差別化要因
• 非公開会社
  • 主要新興企業一覧
  • 地域ネットワークマップ
• 企業プロファイル
  • Curemark LLC
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Bristol-Myers Squibb Company
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Merck &Co., Inc.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Novartis AG
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Eli Lilly and Company
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Pfizer Inc.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Johnson &Johnson Services, Inc.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Otsuka Pharmaceutical Co., Ltd.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Yamo Pharmaceuticals
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • F. Hoffmann-La Roche Ltd.
    • 会社概要
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Axial Therapeutics Inc.
    • 会社概要
    • 製品のベンチマーク
    • 戦略的イニシアチブ

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Regulatory Framework
• Table 4 Global Autism Spectrum Disorder Treatment Market, By Region, 2018 - 2030 (USD Million)
• Table 5 Global Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 6 Global Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
• Table 7 Global Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 8 North America Autism Spectrum Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
• Table 9 North America Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 10 North America Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
• Table 11 North America Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 12 U.S. Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 13 U.S. Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
• Table 14 U.S. Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 15 Canada Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 16 Canada Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
• Table 17 Canada Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 18 Europe Autism Spectrum Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
• Table 19 Europe Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 20 Europe Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
• Table 21 Europe Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 22 Germany Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 23 Germany Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
• Table 24 Germany Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 25 U.K. Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 26 U.K. Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
• Table 27 U.K. Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 28 France Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 29 France Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
• Table 30 France Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 31 Italy Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 32 Italy Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
• Table 33 Italy Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 34 Spain Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 35 Spain Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
• Table 36 Spain Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 37 Denmark Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 38 Denmark Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
• Table 39 Denmark Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 40 Sweden Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 41 Sweden Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
• Table 42 Sweden Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 43 Norway Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 44 Norway Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
• Table 45 Norway Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 46 Asia Pacific Autism Spectrum Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
• Table 47 Asia Pacific Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 48 Asia Pacific Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
• Table 49 Asia Pacific Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 50 Japan Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 51 Japan Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
• Table 52 Japan Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 53 China Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 54 China Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
• Table 55 China Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 56 India Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 57 India Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
• Table 58 India Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 59 South Korea Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 60 South Korea Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
• Table 61 South Korea Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 62 Australia Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 63 Australia Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
• Table 64 Australia Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 65 Thailand Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 66 Thailand Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
• Table 67 Thailand Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 68 Latin America Autism Spectrum Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
• Table 69 Latin America Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 70 Latin America Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
• Table 71 Latin America Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 72 Brazil Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 73 Brazil Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
• Table 74 Brazil Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 75 Mexico Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 76 Mexico Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
• Table 77 Mexico Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 78 Argentina Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 79 Argentina Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
• Table 80 Argentina Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 81 Middle East & Africa Autism Spectrum Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
• Table 82 Middle East & Africa Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 83 Middle East & Africa Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
• Table 84 Middle East & Africa Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 85 Saudi Arabia Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 86 Saudi Arabia Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
• Table 87 Saudi Arabia Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 88 South Africa Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 89 South Africa Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
• Table 90 South Africa Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 91 UAE Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 92 UAE Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
• Table 93 UAE Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 94 Kuwait Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 95 Kuwait Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
• Table 96 Kuwait Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Autism Spectrum Disorder Treatment Market Segmentation
• Fig. 2 Market Research Process
• Fig. 3 Data Triangulation Techniques
• Fig. 4 Primary Research Pattern
• Fig. 5 Market Research Approaches
• Fig. 6 Value - Chain - Based Sizing & Forecasting
• Fig. 7 QFD Modeling For Market Share Assessment
• Fig. 8 Market Formulation & Validation
• Fig. 9 Commodity Flow Analysis
• Fig. 10 Market Snapshot (2022) (USD Million)
• Fig. 11 Segment Snapshot (2022) (USD Million)
• Fig. 12 Segment Snapshot (2022) (USD Million)
• Fig. 13 Competitive Snapshot
• Fig. 14 Penetration and Growth Prospect Mapping
• Fig. 15 Autism Spectrum Disorder Treatment Market Driver Impact
• Fig. 16 Autism Spectrum Disorder Treatment Market Restraint Impact
• Fig. 17 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
• Fig. 18 Porter's Five Forces Analysis
• Fig. 19 Autism Spectrum Disorder Treatment Market: Treatment Type Outlook and Key Takeaways
• Fig. 20 Autism Spectrum Disorder Treatment Market: Treatment Type Movement Analysis
• Fig. 21 Antipsychotic Drugs Market Estimates and Forecast, 2018 - 2030 (USD Million)
• Fig. 22 Antimetabolites Market Estimates and Forecast, 2018 - 2030 (USD Million)
• Fig. 23 Selective Serotonin Reuptake Inhibitors Market Estimates and Forecast, 2018 - 2030 (USD Million)
• Fig. 24 StimulantsMarket Estimates and Forecast, 2018 - 2030 (USD Million)
• Fig. 25 Sleep Medications Market Estimates and Forecast, 2018 - 2030 (USD Million)
• Fig. 26 OthersMarket Estimates and Forecast, 2018 - 2030 (USD Million)
• Fig. 27 Autism Spectrum Disorder Treatment Market: Application Outlook and Key Takeaways
• Fig. 28 Autism Spectrum Disorder Treatment Market: Application Movement Analysis
• Fig. 29 Autistic Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
• Fig. 30 Asperger Syndrome Market Estimates and Forecast, 2018 - 2030 (USD Million)
• Fig. 31 Pervasive Developmental Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
• Fig. 32OthersMarket Estimates and Forecast, 2018 - 2030 (USD Million)
• Fig. 33 Autism Spectrum Disorder Treatment Market: Distribution Channel Outlook and Key Takeaways
• Fig. 34 Autism Spectrum Disorder Treatment Market: Distribution Channel Movement Analysis
• Fig. 35 Hospital Pharmacy Market Estimates and Forecast, 2018 - 2030 (USD Million)
• Fig. 36 Retail Pharmacy Market Estimates and Forecast, 2018 - 2030 (USD Million)
• Fig. 37 Online pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 38 Regional Marketplace: Key Takeaways
• Fig. 39 North America: SWOT analysis
• Fig. 40 North America Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 41 U.S. Country Dynamics
• Fig. 42 U.S. Target Disease Prevalence
• Fig. 43 U.S. Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Canada Country Dynamics
• Fig. 43 Canada Target Disease Prevalence
• Fig. 44 Canada Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 45 Europe: SWOT analysis
• Fig. 46 Europe Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 47 Germany Country Dynamics
• Fig. 48 Germany Target Disease Prevalence
• Fig. 49 Germany Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 50 U.K. Country Dynamics
• Fig. 51 U.K. Target Disease Prevalence
• Fig. 52 U.K. Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 53 France Country Dynamics
• Fig. 54 France Target Disease Prevalence
• Fig. 55 France Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 56 Italy Country Dynamics
• Fig. 57 Italy Target Disease Prevalence
• Fig. 58 Italy Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 59 Spain Country Dynamics
• Fig. 60 Spain Target Disease Prevalence
• Fig. 61 Spain Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 62 Denmark Country Dynamics
• Fig. 63 Denmark Target Disease Prevalence
• Fig. 64 Denmark Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 65 Sweden Country Dynamics
• Fig. 66 Sweden Target Disease Prevalence
• Fig. 67 Sweden Autism Spectrum Disorder Treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 68 Norway Country Dynamics
• Fig. 69 Norway Target Disease Prevalence
• Fig. 70 Norway Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 73 Rest of Europe Autism Spectrum Disorder Treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 74 Asia Pacific: SWOT Analysis
• Fig. 75 Asia Pacific Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 76 Japan Country Dynamics
• Fig. 77 Japan Target Disease Prevalence
• Fig. 78 Japan Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 79 China Country Dynamics
• Fig. 80 China Target Disease Prevalence
• Fig. 81 China Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 80 India Country Dynamics
• Fig. 83 India Target Disease Prevalence
• Fig. 84 India Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 85 Australia Country Dynamics
• Fig. 86 Australia Target Disease Prevalence
• Fig. 87 Australia Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 88 South Korea Country Dynamics
• Fig. 89 South Korea Target Disease Prevalence
• Fig. 90 South Korea Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 91 Thailand Country Dynamics
• Fig. 92 Thailand Target Disease Prevalence
• Fig. 93 Thailand Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 96 Rest of APAC Autism Spectrum Disorder Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 97 Latin America (LATAM): SWOT Analysis
• Fig. 98 Latin America Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 99 Brazil Country Dynamics
• Fig. 100 Brazil Target Disease Prevalence
• Fig. 101 Brazil Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 102 Mexico Country Dynamics
• Fig. 103 Mexico Target Disease Prevalence
• Fig. 104 Mexico Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 105 Argentina Country Dynamics
• Fig. 106 Argentina Target Disease Prevalence
• Fig. 107 Argentina Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 110 Rest of LATAM Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 111 Middle East & Africa (MEA): SWOT Analysis
• Fig. 112 Middle East & Africa (MEA) Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 113 South Africa Country Dynamics
• Fig. 114 Target Disease Prevalence
• Fig. 115 South Africa Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 116 Saudi Arabia Country Dynamics
• Fig. 117 Saudi ArabiaTarget disease prevalence
• Fig. 118 Saudi Arabia Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 119 UAE Country Dynamics
• Fig. 120 UAE Target Disease Prevalence
• Fig. 121 UAE Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 122 Kuwait Country Dynamics
• Fig. 123 Kuwait Target Disease Prevalence
• Fig. 124 Kuwait Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 127 Rest of MEA Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 128 Heat Map Analysis
• Fig. 129 Strategic Framework

Autism Spectrum Disorder Treatment Market Growth & Trends:

The global autism spectrum disorder treatment market size is expected to reach USD 3.28 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 6.1% from 2023 to 2030. Many of the experimental autism spectrum disorder (ASD) drugs in the academic studies and pharma pipeline are assessing important theories about how the genetic fingerprint and brain contribute to the development of autism. Some of the pipeline drugs include AB-2004 & AB-2004 PTR by Axial Therapeutics, Inc., Zygel by Zynerba Pharmaceuticals, Inc., and INP105 (Olanzapine) by Impel Pharmaceuticals Inc.

In July 2022, Impel Pharmaceuticals Inc. initiated the first patient dose in phase 2a study evaluating INP-105 to treat acute agitation in adolescents with autism spectrum disorder (ASD). The company uses its Precision Olfactory Delivery (POD) technology to deliver medicine to the upper nasal part and increase the absorption of the drug, without the need for injection. Thus, technological advancement in drug delivery is anticipated to drive the market.

In May 2020, HARMAN International and F. Hoffmann-La Roche Ltd. entered into a global partnership to develop a digital therapeutic platform for individuals with ASD. Under this partnership, Harman and Samsung combined their extensive technology with F. Hoffmann-La Roche Ltd.'s leadership in neuroscience to develop innovative therapies for the treatment of ASD.

Rising awareness and funding for research and development of autism spectrum disorder are expected to positively contribute to the growth of the market. For instance, the Sapienza Universita di Roma every year celebrates the 2nd of April as 'World Autism Awareness Day' with an aim to increase awareness about the disease and its treatment benefits among physicians and patients. Furthermore, in November 2022, the Defiance County Board of Developmental Disabilities/Good Samaritan School and the Andrew Jimenez Autism Fund received a donation of USD 1000 from Buckeye Roofing and Exteriors owner to support the efforts to raise awareness about ASD, subsequently creating an opportunity for the market growth.

Autism Spectrum Disorder Treatment Market Report Highlights:

• By treatment type, the stimulants segment accounted for the largest share in 2022. This can be attributed to the availability of FDA-approved stimulants for the symptom management of disease in the market

• Based on application, the autistic disorder segment dominated the market in 2022 owing to the rising incidence of the disease. As per the 3 cohort studies, the incidence of ASD was found to be more than 3% of the population as of May 2021

• The hospital pharmacy segment held the second-largest share in 2022. This growth can be attributed to an increase in inpatient visits for the diagnosis and treatment of patients with disease

• North America dominated the global market in 2022 owing to factors such as high awareness among healthcare professionals about autism spectrum disorder treatment, the availability of drugs for treatment, and an increase in disease prevalence

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market Segmentation and Scope
  • 1.1.1 Segment Scope
  • 1.1.2 Regional Scope
  • 1.1.3 Estimates and Forecast Timeline
• 1.2 Research Methodology
• 1.3 Information Procurement
  • 1.3.1 Purchased Database:
  • 1.3.2 GVR's Internal Database
  • 1.3.3 Secondary Sources
  • 1.3.4 Primary Research
  • 1.3.5 Details of Primary Research
• 1.4 Information or Data Analysis
  • 1.4.1 Data Analysis Models
• 1.5 Market Formulation and Validation
• 1.6 Model Details
  • 1.6.1 Commodity Flow Analysis
    • 1.6.1.1 Approach: Commodity Flow Approach
• 1.7 Research Assumptions
• 1.8 List of Secondary Sources
• 1.9 List of Abbreviations
• 1.10 Objectives
  • 1.10.1 Objective 1
  • 1.10.2 Objective 2
  • 1.10.3 Objective 3
  • 1.10.4 Objective 4

Chapter 2 Executive Summary

• 2.1 Market Snapshot
• 2.2 Segment Snapshot
• 2.3 Competitive Snapshot

Chapter 3 Autism Spectrum Disorder Treatment: Market Variables, Trends, and Scope

• 3.1 Market Lineage Outlook
  • 3.1.1 Central Nervous System Therapeutics Market
• 3.2 Penetration and Growth Prospect Mapping
• 3.3 Regulatory Landscape
• 3.4 Market Dynamics
• 3.5 Market Driver Analysis
  • 3.5.1 Increasing Prevalence of ASD
  • 3.5.2 Increasing Awareness About ASD Among Physicians and Patients
  • 3.5.3 Increasing Funding for ASD R&D
• 3.6 Market Restraint Analysis
  • 3.6.1 Lack of Approved Drugs
  • 3.6.2 Failures of Preclinical to Clinical Translation of Targeted Treatments
• 3.7 PESTEL Analysis
• 3.8 Industry Analysis-Porter's Five Forces
• 3.9 Pipeline Analysis

Chapter 4 Autism Spectrum Disorder Treatment Market: Segment Analysis, by Treatment Type, 2018 - 2030 (USD Million)

• 4.1 Autism Spectrum Disorder Treatment Market: Treatment Type Movement Analysis
• 4.2 Antipsychotic Drugs
  • 4.2.1 Antipsychotic Drugs Market, 2018 - 2030 (USD Million)
  • 4.2.2 Selective Serotonin Reuptake Inhibitors
    • 4.2.2.1 Selective Serotonin Reuptake Inhibitors Market, 2018 - 2030 (USD Million)
  • 4.2.3 Stimulants
    • 4.2.3.1 Stimulants Market, 2018 - 2030 (USD Million)
  • 4.2.4 Sleep Medication
    • 4.2.4.1 Sleep Medication Market, 2018 - 2030 (USD Million)
  • 4.2.5 Others
    • 4.2.5.1 Others Market, 2018 - 2030 (USD Million)

Chapter 5 Autism Spectrum Disorder Treatment Market: Segment Analysis, by Application, 2018 - 2030 (USD Million)

• 5.1 Autism Spectrum Disorder Treatment Market: Application Movement Analysis
• 5.2 Autistic Disorder
  • 5.2.1 Autistic Disorder Market, 2018 - 2030 (USD Million)
• 5.3 Asperger Syndrome
  • 5.3.1 Asperger Syndrome Market, 2018 - 2030 (USD Million)
• 5.4 Pervasive Developmental Disorder
  • 5.4.1 Pervasive Developmental Disorder Market, 2018 - 2030 (USD Million)
• 5.5 Others
  • 5.5.1 Others Market, 2018 - 2030 (USD Million)

Chapter 6 Autism Spectrum Disorder Treatment Market: Segment Analysis, by Distribution Channel, 2018 - 2030 (USD Million)

• 6.1 Autism Spectrum Disorder Treatment Market: Distribution Channel Movement Analysis
• 6.2 Hospital Pharmacy
  • 6.2.1 Hospital Pharmacy Market, 2018 - 2030 (USD Million)
• 6.3 Retail Pharmacy
  • 6.3.1 Retail Pharmacy Market, 2018 - 2030 (USD Million)
• 6.4 Online Pharmacy
  • 6.4.1 Online Pharmacy Market, 2018 - 2030 (USD Million)

Chapter 7 Europe Autism Spectrum Disorder Treatment Market: Regional Estimates and Trend Analysis, by Drug Class, Application, Route of Administration, & Distribution Channel

• 7.1 North America
  • 7.1.1 SWOT Analysis:
    • 7.1.1.1 North America Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.1.2 U.S.
    • 7.1.2.1 Country Dynamics
    • 7.1.2.2 Target Disease Prevalence
    • 7.1.2.3 Competitive Scenario
    • 7.1.2.4 Regulatory Framework
    • 7.1.2.5 Reimbursement Scenario
    • 7.1.2.6 U.S. Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.1.3 Canada
    • 7.1.3.1 Country Dynamics
    • 7.1.3.2 Target Disease Prevalence
    • 7.1.3.3 Competitive Scenario
    • 7.1.3.4 Regulatory Framework
    • 7.1.3.5 Reimbursement Scenario
    • 7.1.3.6 Canada Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.2 Europe
  • 7.2.1 SWOT Analysis:
    • 7.2.1.1 Europe Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.2.2 U.K.
    • 7.2.2.1 Country Dynamics
    • 7.2.2.2 Target Disease Prevalence
    • 7.2.2.3 Competitive Scenario
    • 7.2.2.4 Regulatory Framework
    • 7.2.2.5 Reimbursement Scenario
    • 7.2.2.6 Prescription and Dispensing Scenario
    • 7.2.2.7 U.K. Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.2.3 Germany
    • 7.2.3.1 Country Dynamics
    • 7.2.3.2 Target Disease Prevalence
    • 7.2.3.3 Competitive Scenario
    • 7.2.3.4 Regulatory Framework
    • 7.2.3.5 Reimbursement Scenario
    • 7.2.3.6 Germany Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.2.4 France
    • 7.2.4.1 Country Dynamics
    • 7.2.4.2 Target Disease Prevalence
    • 7.2.4.3 Competitive Scenario
    • 7.2.4.4 Regulatory Framework
    • 7.2.4.5 Reimbursement Scenario
    • 7.2.4.6 France Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.2.5 Italy
    • 7.2.5.1 Country Dynamics
    • 7.2.5.2 Target Disease Prevalence
    • 7.2.5.3 Competitive Scenario
    • 7.2.5.4 Regulatory Framework
    • 7.2.5.5 Reimbursement Scenario
    • 7.2.5.6 Italy Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.2.6 Spain
    • 7.2.6.1 Country Dynamics
    • 7.2.6.2 Target Disease Prevalence
    • 7.2.6.3 Competitive Scenario
    • 7.2.6.4 Regulatory Framework
    • 7.2.6.5 Reimbursement Scenario
    • 7.2.6.6 Spain Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.2.7 Denmark
    • 7.2.7.1 Country Dynamics
    • 7.2.7.2 Target Disease Prevalence
    • 7.2.7.3 Competitive Scenario
    • 7.2.7.4 Regulatory Framework
    • 7.2.7.5 Reimbursement Scenario
    • 7.2.7.6 Denmark Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.2.8 Sweden
    • 7.2.8.1 Country Dynamics
    • 7.2.8.2 Target Disease Prevalence
    • 7.2.8.3 Competitive Scenario
    • 7.2.8.4 Regulatory Framework
    • 7.2.8.5 Reimbursement Scenario
    • 7.2.8.6 Sweden Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.2.9 Norway
    • 7.2.9.1 Country Dynamics
    • 7.2.9.2 Target Disease Prevalence
    • 7.2.9.3 Competitive Scenario
    • 7.2.9.4 Regulatory Framework
    • 7.2.9.5 Reimbursement Scenario
    • 7.2.9.6 Norway Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.2.11 Rest of Europe
    • 7.2.11.1 Rest of Europe Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.3. Asia Pacific
  • 7.3.1 SWOT Analysis:
    • 7.3.1.1 Asia PacificAutism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.2 Japan
    • 7.3.2.1 Country Dynamics
    • 7.3.2.2 Target Disease Prevalence
    • 7.3.2.3 Competitive Scenario
    • 7.3.2.4 Regulatory Framework
    • 7.3.2.5 Reimbursement Scenario
    • 7.3.2.6 Prescription and Dispensing Scenario
    • 7.3.2.7 Japan Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.3 China
    • 7.3.3.1 Country Dynamics
    • 7.3.3.2 Target Disease Prevalence
    • 7.3.3.3 Competitive Scenario
    • 7.3.3.4 Regulatory Framework
    • 7.3.3.5 Reimbursement Scenario
    • 7.3.3.6 China Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.4 India
    • 7.3.4.1 Country Dynamics
    • 7.3.4.2 Target Disease Prevalence
    • 7.3.4.3 Competitive Scenario
    • 7.3.4.4 Regulatory Framework
    • 7.3.4.5 Reimbursement Scenario
    • 7.3.4.6 India Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.5 Australia
    • 7.3.5.1 Country Dynamics
    • 7.3.5.2 Target Disease Prevalence
    • 7.3.5.3 Competitive Scenario
    • 7.3.5.4 Regulatory Framework
    • 7.3.5.5 Reimbursement Scenario
    • 7.3.5.6 Australia Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.6 South Korea
    • 7.3.6.1 Country Dynamics
    • 7.3.6.2 Target Disease Prevalence
    • 7.3.6.3 Competitive Scenario
    • 7.3.6.4 Regulatory Framework
    • 7.3.6.5 Reimbursement Scenario
    • 7.3.6.6 South Korea Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.7 Thailand
    • 7.3.7.1 Country Dynamics
    • 7.3.7.2 Target Disease Prevalence
    • 7.3.7.3 Competitive Scenario
    • 7.3.7.4 Regulatory Framework
    • 7.3.7.5 Reimbursement Scenario
    • 7.3.7.6 Thailand Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.8 Rest of APAC
    • 7.3.8.1 Rest of APAC Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.4. Latin America
  • 7.4.1 SWOT Analysis:
    • 7.4.1.1 Latin America Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.2 Brazil
    • 7.4.2.1 Country Dynamics
    • 7.4.2.2 Target Disease Prevalence
    • 7.4.2.3 Competitive Scenario
    • 7.4.2.4 Regulatory Framework
    • 7.4.2.5 Reimbursement Scenario
    • 7.4.2.6 Prescription and Dispensing Scenario
    • 7.4.2.7 Brazil Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.3 Mexico
    • 7.4.3.1 Country Dynamics
    • 7.4.3.2 Target Disease Prevalence
    • 7.4.3.3 Competitive Scenario
    • 7.4.3.4 Regulatory Framework
    • 7.4.3.5 Reimbursement Scenario
    • 7.4.3.6 Mexico Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.4 Argentina
    • 7.4.4.1 Country Dynamics
    • 7.4.4.2 Target Disease Prevalence
    • 7.4.4.3 Competitive Scenario
    • 7.4.4.4 Regulatory Framework
    • 7.4.4.5 Reimbursement Scenario
    • 7.4.4.6 Argentina Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.5. Middle East & Africa (MEA)
  • 7.5.1 SWOT Analysis
    • 7.5.1.1 MEA Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2 South Africa
    • 7.5.2.1 Country Dynamics
    • 7.5.2.2 Target Disease Prevalence
    • 7.5.2.3 Competitive Scenario
    • 7.5.2.4 Regulatory Framework
    • 7.5.2.5 Reimbursement Scenario
    • 7.5.2.6 South Africa Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3 Saudi Arabia
    • 7.5.3.1 Country Dynamics
    • 7.5.3.2 Target Disease Prevalence
    • 7.5.3.3 Competitive Scenario
    • 7.5.3.4 Regulatory Framework
    • 7.5.3.5 Reimbursement Scenario
    • 7.5.3.6 Saudi Arabia Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4 UAE
    • 7.5.4.1 Country Dynamics
    • 7.5.4.2 Target Disease Prevalence
    • 7.5.4.3 Competitive Scenario
    • 7.5.4.4 Regulatory Framework
    • 7.5.4.5 Reimbursement Scenario
    • 7.5.4.6 UAE Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.5 Kuwait
    • 7.5.5.1 Country Dynamics
    • 7.5.5.2 Target Disease Prevalence
    • 7.5.5.3 Competitive Scenario
    • 7.5.5.4 Regulatory Framework
    • 7.5.5.5 Reimbursement Scenario
    • 7.5.5.6 Kuwait Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.6 Rest of MEA
    • 7.5.6.1 Rest of MEA Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8 Autism Spectrum Disorder Treatment Market: Competitive Analysis

• 8.1 Recent Developments & Impact Analysis, by Key Market Participants
  • 8.1.1 New Product Launch
  • 8.1.2 Merger and Acquisition
  • 8.1.3 Licensing Agreements
  • 8.1.4 Conferences and Campaigns
• 8.2 Company Categorization
  • 8.2.1 Innovators
  • 8.2.2 Market Leaders
• 8.3 Vendor Landscape
  • 8.3.1 List of Key Distributors and Channel Partners
  • 8.3.2 Key Customers
• 8.4 Public Companies
  • 8.4.1 Key Company Market Share Analysis, 2022
  • 8.4.2 Company Market Position Analysis
  • 8.4.3 Heat Map Analysis
  • 8.4.4 Competitive Dashboard Analysis
    • 8.4.4.1 Market Differentiators
• 8.5 Private Companies
  • 8.5.1 List of Key Emerging Companies
  • 8.5.2 Regional Network Map
• 8.6 Company Profiles
  • 8.6.1.Curemark LLC
  • 8.6.1.1 Company Overview
  • 8.6.1.2 Financial Performance
  • 8.6.1.3 Product Benchmarking
  • 8.6.1.4 Strategic Initiatives
  • 8.6.2 Bristol - Myers Squibb Company
    • 8.6.2.1 Company Overview
    • 8.6.2.2 Financial Performance
    • 8.6.2.3 Product Benchmarking
    • 8.6.2.4 Strategic Initiatives
  • 8.6.3 Merck & Co., Inc.
    • 8.6.3.1 Company Overview
    • 8.6.3.2 Financial Performance
    • 8.6.3.3 Product Benchmarking
    • 8.6.3.4 Strategic Initiatives
  • 8.6.4 Novartis AG
    • 8.6.4.1 Company Overview
    • 8.6.4.2 Financial Performance
    • 8.6.4.3 Product Benchmarking
    • 8.6.4.4 Strategic Initiatives
  • 8.6.5 Eli Lilly and Company
    • 8.6.5.1 Company Overview
    • 8.6.5.2 Financial Performance
    • 8.6.5.3 Product Benchmarking
    • 8.6.5.4 Strategic Initiatives
  • 8.6.6 Pfizer Inc.
    • 8.6.6.1 Company Overview
    • 8.6.6.2 Financial Performance
    • 8.6.6.3 Product Benchmarking
    • 8.6.6.4 Strategic Initiatives
  • 8.6.7 Johnson & Johnson Services, Inc.
    • 8.6.7.1 Company Overview
    • 8.6.7.2 Financial Performance
    • 8.6.7.3 Product Benchmarking
    • 8.6.7.4 Strategic Initiatives
  • 8.6.8 Otsuka Pharmaceutical Co., Ltd.
    • 8.6.8.1 Company Overview
    • 8.6.8.2 Financial Performance
    • 8.6.8.3 Product Benchmarking
    • 8.6.8.4 Strategic Initiatives
  • 8.6.9 Yamo Pharmaceuticals
    • 8.6.8.1 Company Overview
    • 8.6.9.2 Financial Performance
    • 8.6.9.3 Product Benchmarking
    • 8.6.9.4 Strategic Initiatives
  • 8.6.10 F. Hoffmann - La Roche Ltd.
    • 8.6.10.1 Company Overview
    • 8.6.10.2 Product Benchmarking
    • 8.6.10.3 Strategic Initiatives
  • 8.6.11 Axial Therapeutics Inc.
    • 8.6.11.1 Company Overview
    • 8.6.11.2 Product Benchmarking
    • 8.6.11.3 Strategic Initiatives